|
1
|
Semba RD, Kumwenda N, Hoover DR, Taha TE,
Quinn TC, Mtimavalye L, Biggar RJ, Broadhead R, Miotti PG, Sokoll
LJ, et al: Human immunodeficiency virus load in breast milk,
mastitis, and mother-to-child transmission of human
immunodeficiency virus type 1. J Infect Dis. 180:93–98. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Attia S, Egger M, Müller M, Zwahlen M and
Low N: Sexual transmission of HIV according to viral load and
antiretroviral therapy: Systematic review and meta-analysis. AIDS.
23:1397–1404. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Macías J, Palacios RB, Claro E, Vargas J,
Vergara S, Mira JA, Merchante N, Corzo JE and Pineda JA: High
prevalence of hepatitis C virus infection among noninjecting drug
users: Association with sharing the inhalation implements of crack.
Liver Int. 28:781–786. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sulkowski MS, Mast EE, Seeff LB and Thomas
DL: Hepatitis C virus infection as an opportunistic disease in
persons infected with human immunodeficiency virus. Clin Infect
Dis. 30:(Suppl 1). S77–S84. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Soriano V, Vispo E, Labarga P, Medrano J
and Barreiro P: Viral hepatitis and HIV co-infection. Antiviral
Res. 85:303–315. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
de Lédinghen V, Barreiro P, Foucher J,
Labarga P, Castéra L, Vispo ME, Bernard PH, Martin-Carbonero L,
Neau D, García-Gascó P, et al: Liver fibrosis on account of chronic
hepatitis C is more severe in HIV-positive than HIV-negative
patients despite antiretroviral therapy. J Viral Hepat. 15:427–433.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lavanchy D: Hepatitis B virus
epidemiology, disease burden, treatment and current and emerging
prevention and control measures. J Viral Hepat. 11:97–107. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cockerham L, Scherzer R, Zolopa A, Rimland
D, Lewis CE, Bacchetti P, Grunfeld C, Shlipak M and Tien PC:
Association of HIV infection, demographic and cardiovascular risk
factors with all-cause mortality in the recent HAART era. J Acquir
Immune Defic Syndr. 53:102–106. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hernandez MD and Sherman KE: HIV/hepatitis
C coinfection natural history and disease progression. Curr Opin
HIV AIDS. 6:478–482. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li L, Bao ZY, Sui HS, Liu SY, Zhuang DM,
Liu YJ, Miao WQ, Li Z and Li JY: Investigation on HCV co-infection
in HIV-infected people in some areas of China. Zhongguo Ai Zi Bing
Xing Bing. 14:9–11. 2008.(In Chinese).
|
|
11
|
Yin N, Mei S and Zhang LQ: Outbreak of HIV
and HCV co-infection among intravenous drug users and illegal blood
donors in China. Zhongguo Kang Gan Ran Hua Liao Za Zhi. 2:67–69.
2002.(In Chinese).
|
|
12
|
Ma JX, Wang JR, Shen YZ, Zhang RF, Liu XN,
Jiang XY, Sun HQ and Lu HZ: Clinical epidemiology studies on
HIV-1/AIDS subjects co-infected with HBV and/or HCV in Shanghai.
Wei Sheng Wu Yu Gan Ran. 1:207–210. 2006.(In Chinese).
|
|
13
|
Xia YH, McLaughlin MM, Chen W, Ling L and
Tucker JD: HIV and hepatitis C virus testing delays at methadone
clinics in Guangdong Province, China. PLoS One. 8:e667872013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xia YH, Chen W, Tucker JD, Wang C and Ling
L: HIV and hepatitis C virus test uptake at methadone clinics in
Southern China: Opportunities for expanding detection of bloodborne
infections. BMC Public Health. 13:8992013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Caliendo AM, Gilbert DN, Ginocchio CC,
Hanson KE, May L, Quinn TC, Tenover FC, Alland D, Blaschke AJ,
Bonomo RA, et al: Infectious Diseases Society of America (IDSA):
Better tests, better care: Improved diagnostics for infectious
diseases. Clin Infect Dis. 57:(Suppl 3). S139–S170. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su Q, Liang H, Cen P, Bi Z and Zhou P: HIV
type 1 subtypes based on the pol gene and drug resistance mutations
among antiretroviral-naive patients from Guangxi, Southern China.
AIDS Res Hum Retroviruses. 28:725–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ and
Henderson BE: Hepatitis B virus, aflatoxins, and hepatocellular
carcinoma in southern Guangxi, China. Cancer Res. 49:2506–2509.
1989.PubMed/NCBI
|
|
18
|
Tian D, Li L, Liu Y, Li H, Xu X and Li JD:
Different HCV genotype distributions of HIV-infected individuals in
Henan and Guangxi, China. PLoS One. 7:e503432012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sanger F, Nicklen S and Coulson AR: DNA
sequencing with chain-terminating inhibitors. Proc Natl Acad Sci
USA. 74:5463–5467. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chinchai T, Labout J, Noppornpanth S,
Theamboonlers A, Haagmans BL, Osterhaus AD and Poovorawan Y:
Comparative study of different methods to genotype hepatitis C
virus type 6 variants. J Virol Methods. 109:195–201. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moreira S, Garcia RF, Gutberlet A, Bertol
BC, Ferreira LE, Mde S Pinho and de França PH: A straightforward
genotyping of the relevant IL28B SNPs for the prediction of
hepatitis C treatment outcome. J Virol Methods. 184:93–97. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fattovich G, Stroffolini T, Zagni I and
Donato F: Hepatocellular carcinoma in cirrhosis: incidence and risk
factors. Gastroenterology. 27:(Suppl 1). S35–S50. 2004. View Article : Google Scholar
|
|
24
|
Moradpour D and Blum HE: Pathogenesis of
hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 17:477–483.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Williams R: Global challenges in liver
disease. Hepatology. 44:521–526. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taye S and Lakew M: Impact of hepatitis C
virus co-infection on HIV patients before and after highly active
antiretroviral therapy: an immunological and clinical chemistry
observation, Addis Ababa, Ethiopia. BMC Immunol. 17:14–23.
2013.
|
|
27
|
Bouare N, Gothot A, Delwaide J, Bontems S,
Vaira D, Seidel L, Gerard P and Gerard C: Epidemiological profiles
of human immunodeficiency virus and hepatitis C virus infections in
Malian women: Risk factors and relevance of disparities. World J
Hepatol. 5:196–205. 2013.PubMed/NCBI
|
|
28
|
Merchante N, Girón-González JA,
González-Serrano M, Torre-Cisneros J, García-García JA, Arizcorreta
A, Ruiz-Morales J, Cano-Lliteras P, Lozano F, Martínez-Sierra C, et
al: Grupo Andaluz para el Estudio de las Enfermedades Infecciosas:
Survival and prognostic factors of HIV-infected patients with
HCV-related end-stage liver disease. AIDS. 20:49–57. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
García-Samaniego J, Rodríguez M, Berenguer
J, Rodríguez-Rosado R, Carbó J, Asensi V and Soriano V:
Hepatocellular carcinoma in HIV-infected patients with chronic
hepatitis C. Am J Gastroenterol. 96:179–183. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hadush H, Gebre-Selassie S and Mihret A:
Hepatitis C virus and human immunodeficiency virus coinfection
among attendants of voluntary counseling and testing centre and HIV
follow up clinics in Mekelle Hospital. Pan Afr Med J. 14:1072013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang KM, Thimme R, Melpolder JJ, Oldach
D, Pemberton J, Moorhead-Loudis J, McHutchison JG, Alter HJ and
Chisari FV: Differential CD4(+) and CD8(+) T-cell responsiveness in
hepatitis C virus infection. Hepatology. 33:267–276. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Riestra S, Fernández E, Rodríguez M and
Rodrigo L: Hepatitis C virus infection in heterosexual partners of
HCV carriers. J Hepatol. 22:509–510. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sherman KE, Shire NJ, Rouster SD, Peters
MG, Koziel M James, Chung RT and Horn PS: Viral kinetics in
hepatitis C or hepatitis C/human immunodeficiency virus-infected
patients. Gastroenterology. 128:313–327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Briat A, Dulioust E, Galimand J, Fontaine
H, Chaix ML, Letur-Könirsch H, Pol S, Jouannet P, Rouzioux C and
Leruez-Ville M: Hepatitis C virus in the semen of men coinfected
with HIV-1: Prevalence and origin. AIDS. 19:1827–1835. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Taylor LE, Swan T and Mayer KH: HIV
coinfection with hepatitis C virus: Evolving epidemiology and
treatment paradigms. Clin Infect Dis. 55:(Suppl 1). S33–S42. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Podlekareva D, Bannister W, Mocroft A,
Abrosimova L, Karpov I, Lundgren JD and Kirk O: EuroSIDA Study
Group: The EuroSIDA study: Regional differences in the HIV-1
epidemic and treatment response to antiretroviral therapy among
HIV-infected patients across Europe-a review of published results.
Cent Eur J Public Health. 16:99–105. 2008.PubMed/NCBI
|
|
37
|
Liu Z, Jiang Y, Wu Hao, Xiao Y, Zhang YH,
Pan PL and Xiang Z: Mutual effect of HIV/HCV Co-infection on
laboratory diagnosis. Chin J Lab Med. 28:691–693. 2005.
|
|
38
|
Mboto CI, Fielder M, Davies-Russell A and
Jewell AP: Prevalence of HIV-1, HIV-2, hepatitis C and co-infection
in the gambia. West Afr J Med. 28:16–19. 2009.PubMed/NCBI
|
|
39
|
Onakewhor JU and Okonofua FE: The
prevalence of dual human immunodeficiency virus/hepatitis C virus
(HIV/HCV) infection in asymptomatic pregnant women in Benin City,
Nigeria. Afr J Reprod Health. 13:97–108. 2009.PubMed/NCBI
|
|
40
|
Amin J, Kaye M, Skidmore S, Pillay D,
Cooper DA and Dore GJ: HIV and hepatitis C coinfection within the
CAESAR study. HIV Med. 5:174–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Walusansa V and Kagimu M: Screening for
hepatitis C among HIV positive patients at Mulago hospital in
Uganda. Afr Health Sci. 9:143–146. 2009.PubMed/NCBI
|
|
42
|
Chinese Society of Hepatology, . Chinese
Society of Infectious Diseases and Parasitic Diseases. Principles
for prevention and treatment of hepatitis C. Chin J Int Med (Chin).
43:551–555. 2004.
|
